Eli Lilly And Co LLY experienced a 1.37% increase in pre-market trading on Wednesday, as per Benzinga Pro. This uptick occurs as the company gears up to announce its third-quarter earnings. Wall ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We’re living in a world full of foods that trigger constant hunger, cravings and thoughts about eating. Is it even possible ...

Eli Lilly is set to report Q3 earnings Wednesday, as the pharma giant continues to gain market share in the weight loss drug ...

Shares are up more than 50% already this year, as the story surrounding the company’s GLP-1 drugs gets better and better.

Eli Lilly LLY will report its third-quarter 2024 earnings on Oct. 30, before market open. The Zacks Consensus Estimate for ...

Qsymia’s manufacturer also released postmarketing data showing the oral therapy for weight loss was associated with ...

Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it ...

Get the latest updates on Amgen's upcoming Q3 earnings results, including insights from analysts on key products and trial ...

Tirzepatide is the active ingredient in the U.S. firm's diabetes drug Mounjaro, and weight-loss drug Zepbound. Eli Lilly did ...

今年是美国股市的拆股大年，市场上的一些大公司，如英伟达和沃尔玛都拆分了它们的股票，其中Chipotle Mexican ...

The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the ...